LCM
NVCR icon

Legato Capital Management’s NovoCure NVCR Stock Holding History

Legato Capital Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.28M Buy
84,810
+2,682
+3% +$40.6K 0.11% 284
2026
Q1 		$895K Buy
+82,128
New +$1.03M 0.08% 321
2025
Q2 		– Sell
-36,003
Closed -$642K – 599
2025
Q1 		$642K Sell
36,003
-457
-1% -$10.4K 0.09% 374
2024
Q4 		$1.09M Sell
36,460
-19,107
-34% -$404K 0.14% 270
2024
Q3 		$869K Hold
55,567
– – 0.11% 340
2024
Q2 		$952K Buy
+55,567
New +$977K 0.13% 278

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Legato Capital Management's NVCR Position: Q2 2026 in Review

Legato Capital Management increased its NovoCure (NVCR) stake by 3.3% in Q2 2026, buying an estimated $40.6K and bringing the position to 84,810 shares worth $1.28M. The position accounts for 0.11% of the portfolio, ranked #284.

Legato Capital Management first reported a position in NVCR in Q2 2024 and has held it in 6 quarters since. 216 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Legato Capital Management held 84,810 shares of NovoCure worth $1.28M as of Q2 2026.
  • Legato Capital Management bought 2,682 NovoCure shares in Q2 2026, an estimated $40.6K.
  • NovoCure made up 0.11% of Legato Capital Management's portfolio in Q2 2026, its #284 holding.
  • Legato Capital Management first reported a position in NovoCure in Q2 2024 and has held it in 6 quarters since.
  • 216 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.